Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Endocrinology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown

Diabetes Mellitus, Type 2 Clinical Trials

A listing of Diabetes Mellitus, Type 2 medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (970) clinical trials

To assess the number and type of events associated with body systems related to the heart and blood vessels (cardiovascular system) in patients with type 2 diabetes.

Phase N/A

The primary objective is to confirm the cardiovascular safety of insulin degludec compared to that of insulin glargine.

Phase N/A

This study is to support the development of MK-1293, a proposed follow-on insulin glargine, using Lantus™ (insulin glargine, Sanofi-aventis Pharmaceuticals, Frankfurt, Germany) as the comparator medicinal product. This study will assess the safety and efficacy of MK-1293 compared to Lantus™.

Phase

Endeavor Clinical Trials is conducting a research study evaluating the safety and efficacy of an intramuscular injection in people with Peripheral Artery Disease & Diabetic Foot Ulcers

Phase N/A

Endeavor Clincial Trials is seeking volunteers to participate in a Diabetic Peripheral Neuropathy (DPN) research study.

Phase N/A

The primary efficacy objective is to determine whether treatment with dapagliflozin compared with placebo when added to current background therapy will result in a reduction in the incidence of the composite endpoint of cardiovascular death, myocardial infarction (MI), or ischemic stroke in patients with type 2 diabetes mellitus (T2DM) with ...

Phase

To see if you may be eligible to participate in an OMNEON Clinical Research Program, you will be asked to answer some questions about your health history and current conditions. The information you provide will be kept confidential and will not be shared without your permission or except as required ...

Phase N/A

Dapagliflozin Effect on Cardiovascular Events A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Dapagliflozin 10 mg Once Daily on the Incidence of Cardiovascular Death, Myocardial Infarction or Ischemic Stroke in Patients With Type 2 Diabetes Inclusion Criteria: Provision of informed consent prior to any study specific procedures ...

Phase

If you are a man or woman over the age of 18, you may be eligible to participate in a clinical research study evaluating the safety and effectiveness of an investigational form of insulin to reduce blood sugar levels in individuals with Type 2 Diabetes. There is no cost to ...

Phase N/A

Metabolic Research Institute may have a new path for you to take. To learn more about this study or to see if you qualify to participate, please call: 561-802-3060 You may qualify for an exciting clinical trial. www.metabolic-institute.com/information.htm.

Phase N/A